Christopher I Amos Selected Research

RNA (Ribonucleic Acid)

2/2024	Clonal gene signatures predict prognosis in mesothelioma and lung adenocarcinoma.
1/2023	InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.
1/2023	Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer.
9/2020	A gene expression-based immune signature for lung adenocarcinoma prognosis.
1/2019	A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.
1/2018	A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.
1/2017	Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients.
11/2015	RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients.
1/2015	RNA-Seq Analysis of Differential Splice Junction Usage and Intron Retentions by DEXSeq.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher I Amos Research Topics

Disease

104	Neoplasms (Cancer) 04/2024 - 07/2002
67	Lung Neoplasms (Lung Cancer) 12/2023 - 05/2002
32	Melanoma (Melanoma, Malignant) 01/2023 - 07/2011
18	Rheumatoid Arthritis 07/2013 - 09/2002
12	Carcinogenesis 12/2023 - 10/2003
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 07/2002
11	Breast Neoplasms (Breast Cancer) 01/2024 - 05/2012
11	Adenocarcinoma of Lung 12/2022 - 05/2007
9	Inflammation (Inflammations) 01/2023 - 09/2007
9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2004
9	Adenocarcinoma 01/2019 - 02/2009
7	Glioma (Gliomas) 01/2023 - 04/2014
7	Crohn Disease (Crohn's Disease) 11/2022 - 02/2004
6	Venous Thromboembolism 04/2024 - 01/2021
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 11/2012
6	Polyps 03/2014 - 03/2003
5	Tobacco Use Disorder (Nicotine Dependence) 09/2023 - 06/2006
5	Obesity 01/2022 - 01/2014
5	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 02/2013 - 04/2007
4	Fibrosis (Cirrhosis) 02/2024 - 07/2002
4	Squamous Cell Carcinoma of Head and Neck 11/2022 - 09/2006
4	Neoplasm Metastasis (Metastasis) 10/2020 - 05/2013
4	Autoimmune Diseases (Autoimmune Disease) 07/2010 - 08/2004
4	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 05/2009 - 03/2003
3	Lymphoma (Lymphomas) 04/2024 - 12/2021
3	COVID-19 01/2024 - 08/2021
3	Genetic Predisposition to Disease (Genetic Predisposition) 12/2023 - 09/2004
3	Hemorrhage 05/2023 - 01/2021
3	Oropharyngeal Neoplasms 01/2022 - 12/2016
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 12/2017
3	Carcinoma (Carcinomatosis) 01/2019 - 09/2003
3	Prostatic Neoplasms (Prostate Cancer) 11/2017 - 01/2005
3	Asthma (Bronchial Asthma) 02/2016 - 07/2002
3	Disease Progression 11/2014 - 01/2005
2	Paralysis (Palsy) 04/2024 - 01/2023
2	Mesothelioma 02/2024 - 11/2021
2	Liver Neoplasms (Liver Cancer) 02/2024 - 11/2017
2	Infections 01/2024 - 11/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2023 - 04/2006
2	Pulmonary Embolism 01/2023 - 12/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 05/2016
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 12/2021
2	Hypersensitivity (Allergy) 01/2023 - 02/2016
2	Malignant Mesothelioma 01/2023 - 11/2021
2	Ovarian Neoplasms (Ovarian Cancer) 11/2022 - 11/2018
2	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 11/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 08/2008
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 07/2005
2	Pneumonia (Pneumonitis) 07/2022 - 04/2006

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2003
21	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2003
11	SmokeIBA 12/2023 - 08/2003
9	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2015
9	P-2 (P 2)IBA 12/2023 - 09/2007
8	ORALIT (ORS)IBA 05/2023 - 05/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2006
6	CarcinogensIBA 12/2023 - 03/2003
6	Estrogen ReceptorsIBA 06/2023 - 09/2008
6	AutoantibodiesIBA 01/2023 - 01/2007
6	Messenger RNA (mRNA)IBA 10/2020 - 10/2009
6	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2012 - 05/2008
6	MutagensIBA 02/2011 - 12/2005
5	C-Reactive ProteinIBA 01/2023 - 04/2015
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 09/2002
4	VaccinesIBA 01/2024 - 01/2017
4	Nicotine FDA Link 12/2023 - 09/2011
4	Fatty Acids (Saturated Fatty Acids)IBA 10/2023 - 01/2017
4	Formaldehyde (Formol)FDA Link 01/2023 - 01/2016
4	ParaffinIBA 01/2023 - 01/2016
4	CytokinesIBA 11/2022 - 04/2015
4	Vitamin D FDA LinkGeneric 01/2022 - 03/2013
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 09/2002
4	AntibodiesIBA 01/2019 - 11/2005
4	EnzymesIBA 11/2010 - 08/2002
4	EpitopesIBA 12/2009 - 09/2002
4	Rheumatoid FactorIBA 12/2009 - 07/2005
3	MicroRNAs (MicroRNA)IBA 01/2023 - 11/2014
3	NucleotidesIBA 01/2023 - 10/2004
3	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2014
3	LigandsIBA 11/2021 - 07/2010
3	Peptides (Polypeptides)IBA 01/2018 - 12/2012
3	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2017 - 10/2011
3	Amino Acids FDA Link 01/2017 - 03/2004
3	InterleukinsIBA 12/2015 - 05/2013
3	Genetic Markers (Genetic Marker)IBA 11/2015 - 07/2011
3	cyclic citrullinated peptideIBA 12/2009 - 01/2007
3	Immunoglobulin M (IgM)IBA 12/2009 - 01/2007
3	Anti-Citrullinated Protein AntibodiesIBA 05/2008 - 01/2007
3	Bleomycin (Blenoxane)FDA LinkGeneric 03/2006 - 07/2002
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2023 - 10/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2023 - 01/2019
2	Deoxyribonuclease I (Nickase)IBA 01/2023 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 12/2022
2	Phosphotransferases (Kinase)IBA 11/2022 - 05/2007
2	Tumor Biomarkers (Tumor Markers)IBA 10/2022 - 02/2015
2	LDL CholesterolIBA 07/2022 - 01/2017

Therapy/Procedure

27	Therapeutics 04/2024 - 08/2002
12	Drug Therapy (Chemotherapy) 09/2023 - 07/2002
8	Immunotherapy 12/2022 - 02/2016
3	Cell Transplantation 01/2022 - 01/2021